Around 10% of all thrombotic cerebrovascular events (CVE) occur in young population and in a large proportion of those the trigger remains undetermined. Antiphospholipid antibodies (aPL) are recognised risk factors for ischaemic stroke and recurrent thrombotic events; however, the frequency of aPL in young people with CVE is still an unresolved issue.

The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review

SCIASCIA, Savino;
2014-01-01

Abstract

Around 10% of all thrombotic cerebrovascular events (CVE) occur in young population and in a large proportion of those the trigger remains undetermined. Antiphospholipid antibodies (aPL) are recognised risk factors for ischaemic stroke and recurrent thrombotic events; however, the frequency of aPL in young people with CVE is still an unresolved issue.
2014
N/A
N/A
Anticardiolipin Antibodies; Antiphospholipid Antibodies; Antiphospholipid Syndrome; Autoimmune Diseases
Sciascia, Savino; Sanna, Giovanni; Khamashta, Munther A; Cuadrado, Maria Jose; Erkan, Doruk; Andreoli, Laura; Bertolaccini, Maria Laura
File in questo prodotto:
File Dimensione Formato  
aPL and CVA V1D.doc

Accesso riservato

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 324 kB
Formato Microsoft Word
324 kB Microsoft Word   Visualizza/Apri   Richiedi una copia
35_24942381_4aperto.pdf

Open Access dal 02/10/2015

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 802.87 kB
Formato Adobe PDF
802.87 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1523084
Citazioni
  • ???jsp.display-item.citation.pmc??? 36
  • Scopus 110
  • ???jsp.display-item.citation.isi??? 101
social impact